Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response

Harish Shankaran1, H Steven Wiley, Haluk Resat

  • 1Pacific Northwest National Laboratory, Richland, WA, USA.

Biophysical Journal
|March 15, 2006
PubMed

Insights

Coexpressing human epidermal growth factor receptors (HERs) 1-3 influences cell signaling pathways. This study reveals that specific HER combinations, particularly HER2-HER3 heterodimers, promote cell growth and transformation, impacting cancer prognosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Computational Biology

Background:

  • The human epidermal growth factor receptor (HER/ErbB) system, including EGFR (HER1) and HERs 2-4, is crucial for cell growth.
  • Overexpression of these receptors is linked to poor outcomes in epithelial cancers.

Purpose of the Study:

  • To investigate the impact of coexpressing varying levels of HERs 1-3 on receptor dimerization patterns.
  • To analyze how these dimerization patterns affect cellular responses.

Main Methods:

  • Utilized a detailed kinetic model for HER/ErbB dimerization and trafficking.
  • Employed parameter dependence analysis for experimental design.
  • Used a phenomenological model to link dimerization patterns to biological response.

Main Results:

  • Coexpression of EGFR with HER2 or HER3 shifts signaling to the cell surface and slows signal downregulation.
  • Simultaneous coexpression of HERs 1-3 generates abundant HER2-HER3 heterodimers, potent inducers of cell growth.
  • Low to moderate EGFR, HER2, and HER3 coexpression can mimic the response of high HER2 expression.

Conclusions:

  • HER/ErbB receptor coexpression significantly alters dimerization dynamics and signaling.
  • HER2-HER3 heterodimers play a key role in promoting cell proliferation and transformation.
  • Specific HER coexpression patterns can modulate cellular response to growth signals, with implications for cancer therapy.